Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)
Diego A. Pizzagalli, Moria J. Smoski, Yuen‐Siang Ang, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 10, pp. 1656-1663
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Immune targets for therapeutic development in depression: towards precision medicine
Wayne C. Drevets, Gayle Wittenberg, Edward T. Bullmore, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 3, pp. 224-244
Open Access | Times Cited: 200
Toward a Better Understanding of the Mechanisms and Pathophysiology of Anhedonia: Are We Ready for Translation?
Diego A. Pizzagalli
American Journal of Psychiatry (2022) Vol. 179, Iss. 7, pp. 458-469
Open Access | Times Cited: 94
The Hierarchical Taxonomy of Psychopathology (HiTOP) in psychiatric practice and research
Roman Kotov, David C. Cicero, Christopher Conway, et al.
Psychological Medicine (2022) Vol. 52, Iss. 9, pp. 1666-1678
Closed Access | Times Cited: 90
Positive affect treatment targets reward sensitivity: A randomized controlled trial.
Michelle G. Craske, Alicia E. Meuret, Aileen Echiverri-Cohen, et al.
Journal of Consulting and Clinical Psychology (2023) Vol. 91, Iss. 6, pp. 350-366
Closed Access | Times Cited: 57
Novel drug developmental strategies for treatment‐resistant depression
Éva Borbély, Mária Simon, Eberhard Fuchs, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 6, pp. 1146-1186
Open Access | Times Cited: 68
Personality neuroscience: An emerging field with bright prospects
Colin G. DeYoung, Roger E. Beaty, Erhan Genç, et al.
Personality Science (2022) Vol. 3
Open Access | Times Cited: 42
Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder
Nicolas Singewald, Simone B. Sartori, Andreas Reif, et al.
Neuropharmacology (2023) Vol. 226, pp. 109418-109418
Open Access | Times Cited: 37
Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study
Mark E. Schmidt, Iva Kezic, Vanina Popova, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 9, pp. 1437-1447
Open Access | Times Cited: 14
Positive affect and reward processing in the treatment of depression, anxiety and trauma
Michelle G. Craske, Barnaby D. Dunn, Alicia E. Meuret, et al.
Nature Reviews Psychology (2024)
Closed Access | Times Cited: 10
Psychosis superspectrum II: neurobiology, treatment, and implications
Roman Kotov, William T. Carpenter, David C. Cicero, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 5, pp. 1293-1309
Closed Access | Times Cited: 8
Anhedonia in Depression and Schizophrenia: Brain Reward and Aversion Circuits
Sugai Liang, Yue Wu, Li Hanxiaoran, et al.
Neuropsychiatric Disease and Treatment (2022) Vol. Volume 18, pp. 1385-1396
Open Access | Times Cited: 28
Potential treatment targets for migraine: emerging options and future prospects
Chia‐Chun Chiang, Frank Porreca, Carrie E. Robertson, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 3, pp. 313-324
Closed Access | Times Cited: 7
The computational structure of consummatory anhedonia
Anna Hall, Michael Browning, Quentin J. M. Huys
Trends in Cognitive Sciences (2024) Vol. 28, Iss. 6, pp. 541-553
Open Access | Times Cited: 6
Neurobiology of alcohol seeking behavior
Esi Domi, Ana Domi, Louise Adermark, et al.
Journal of Neurochemistry (2021) Vol. 157, Iss. 5, pp. 1585-1614
Open Access | Times Cited: 38
Nucleus Accumbens Medium Spiny Neuron Subtypes Differentially Regulate Stress-Associated Alterations in Sleep Architecture
Kenneth M. McCullough, Galen Missig, Mykel A. Robble, et al.
Biological Psychiatry (2021) Vol. 89, Iss. 12, pp. 1138-1149
Open Access | Times Cited: 35
Treatment-resistant depression with anhedonia: Integrating clinical and preclinical approaches to investigate distinct phenotypes
Chris Kelly, Kevin B. Freeman, Julie A. Schumacher
Neuroscience & Biobehavioral Reviews (2022) Vol. 136, pp. 104578-104578
Closed Access | Times Cited: 26
Dynorphin / kappa-opioid receptor regulation of excitation-inhibition balance toggles afferent control of prefrontal cortical circuits in a pathway-specific manner
Héctor E. Yarur, Sanne M. Casello, Valerie S. Tsai, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 11, pp. 4801-4813
Open Access | Times Cited: 14
Precision psychiatry and Research Domain Criteria: Implications for clinical trials and future practice
Leanne M. Williams, William T. Carpenter, Carrie M. Carretta, et al.
CNS Spectrums (2023) Vol. 29, Iss. 1, pp. 26-39
Open Access | Times Cited: 13
Opioidergic modulation of monetary incentive delay fMRI responses
Samuel Turton, Peter C.T. Hawkins, Christopher Muller-Pollard, et al.
Psychopharmacology (2025)
Open Access
The Role of Mu-Opioids for Reward and Threat Processing in Humans: Bridging the Gap from Preclinical to Clinical Opioid Drug Studies
Isabell M. Meier, Marie Eikemo, Siri Leknes
Current Addiction Reports (2021) Vol. 8, Iss. 2, pp. 306-318
Open Access | Times Cited: 30
Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders
Aaron Limoges, Héctor E. Yarur, Hugo A. Tejeda
Frontiers in Systems Neuroscience (2022) Vol. 16
Open Access | Times Cited: 21
Endogenous opiates and behavior: 2020
Richard J. Bodnar
Peptides (2022) Vol. 151, pp. 170752-170752
Closed Access | Times Cited: 19
Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors
Hildegard A. Wulf, Caroline A. Browne, Carlos A. Zarate, et al.
Psychopharmacology (2022) Vol. 239, Iss. 7, pp. 2309-2316
Closed Access | Times Cited: 19
Enhancing the Psychometric Properties of the Iowa Gambling Task Using Full Generative Modeling
Holly Sullivan‐Toole, Nathaniel Haines, Kristina Dale, et al.
Computational Psychiatry (2022) Vol. 6, Iss. 1, pp. 189-212
Open Access | Times Cited: 18
From Computation to Clinic
Sarah W. Yip, Deanna M. Barch, Henry W. Chase, et al.
Biological Psychiatry Global Open Science (2022) Vol. 3, Iss. 3, pp. 319-328
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top